Skip to content
lifestyle.longislandreport.org
Animals
Auto
Beauty & Style
Business News
Entertainment
Food
Health
Home & Family
Podcasts
Tech
Travel
Author:
Applied Biologics
Applied Biologics Announces Successful Manufacture of First Research Construct for Disease-Modifying Osteoarthritis Gene Therapy Program
July 14, 2026
Applied Biologics Introduces ECM Preservation Technology™ as the Proprietary Manufacturing Platform Behind XWRAP®
July 9, 2026
Applied Biologics Announces VA Federal Supply Schedule Contract Modification Supporting Long-Term Access to XWRAP®
July 7, 2026
Applied Biologics Announces Expanded Strategic Focus on Surgical Applications of XWRAP®
July 1, 2026
Applied Biologics Announces National Commercial Expansion to Support Continued Growth of XWRAP® and Future Biologic Product Pipeline
June 30, 2026
Applied Biologics Announces Completion of Translational Research Supporting the Biologic Performance of XWRAP®
June 24, 2026
Applied Biologics Announces Submission of Abstract of Single-Layer Amniotic Membrane Plus Standard of Care for Chronic Diabetic Foot Ulcers: An Updated Analysis of The Campx Trial to SAWC Fall 2026
June 23, 2026
Applied Biologics Announces Completion of Planned Enrollment Activities in the CAMPX Randomized Controlled Trial Evaluating XWRAP®
June 17, 2026
Applied Biologics Reports Statistically Significant Improvement in Wound Closure Outcomes in Updated Analyses of the CAMPX Randomized Controlled Trial Evaluating XWRAP®
June 15, 2026
Applied Biologics Launches Preclinical Development Program Focused on Osteoarthritis and Other Degenerative Diseases
June 11, 2026
←
Previous Page
1
2
3
Next Page
→